|
|
| Line 1: |
Line 1: |
| {{Drugbox
| | #REDIRECT [[Moexipril]] |
| | IUPAC_name = (3''S'')-2-[(2''S'')-2-[ [(2''S'')-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid
| |
| | image = Moexipril.png
| |
| | CAS_number = 103775-10-6
| |
| | CAS_supplemental =
| |
| | ATC_prefix = C09
| |
| | ATC_suffix = AA13
| |
| | ATC_supplemental =
| |
| | PubChem = 91270
| |
| | DrugBank =
| |
| | C=27 | H=34 | N=2 | O=7
| |
| | molecular_weight = 498.568 g/mol
| |
| | bioavailability =
| |
| | protein_bound =
| |
| | metabolism =
| |
| | elimination_half-life =
| |
| | excretion =
| |
| | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| |
| | pregnancy_US = D
| |
| | pregnancy_category=
| |
| | legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| |
| | legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| |
| | legal_UK = POM
| |
| | legal_US = Rx-only
| |
| | legal_status =
| |
| | routes_of_administration = Oral
| |
| }}
| |
| {{CMG}}
| |
| | |
| | |
| | |
| '''Moexipril''' (marketed under the tradenames '''Univasc''' and '''Perdix''') is an [[ACE inhibitor]].
| |
| | |
| | |
| | |
| | |
| {{ACE inhibitors}}
| |
| | |
| | |
| [[Category:ACE inhibitors]]
| |
| | |
| {{WH}}
| |
| {{WS}}
| |